drugset / Trial / NCT04415645

Absorption, Metabolism, Excretion, and Mass Balance Study of [14C]-VVZ-149 in Healthy Adult Male Subjects

NCT04415645

Phase 1 Completed 6 enrolled Vivozon, Inc.
NaSingle-groupOpen-labelOther

Summary

This is an open-label, single-dose, absorption, metabolism, excretion, and mass balance study following a single IV infusion of \[14C\]-VVZ-149 in healthy adult male subjects. Whole blood, plasma, urine, and fecal samples will be analyzed for at least 72 hours following the start of infusion to measure total radioactivity and plasma drug concentrations.

Timeline

Start
2020-02-24
Primary completion
2020-03-06
Completion
2020-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject VVZ-149 Small molecule Intravenous

Indications

No indication recorded.